In her latest column, Dr Jane Wilcock explains how viruses like norovirus have resurged and can sometimes cause severe illness ...

Neither the VDH nor the CDC are any longer reporting COVID fatalities or total cases in Vermont or in the US. The ...

Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, helped by better-than-expected sales of its ...

By Julie Steenhuysen, Siddhi Mahatole and Mariam Sunny May 1 (Reuters) - Moderna surpassed Wall Street estimates for ...

Experts fear the summer’s World Cup will become a superspreader event for a host of diseases. Millions of fans are expected ...

Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports ...

A World Cup health security hub to track threats including measles, dengue and Zika virus among football fans is being ...

Moby Strategic Performance and Operational Context. Revenue growth of $0.4 billion in Q1 was primarily driven by the ...

Moderna's first-quarter sales beat expectations, fueled by government deals outside the US and its first UK shipment under a long-term agreement.

Moderna posted Q1 2026 revenue of $400 million, roughly $300 million higher than a year ago and above its own guidance, marking about 300% year‑over‑year growth. The quarter was heavily skewed toward ...

Mock maintained cost targets and year-end liquidity outlook, stating, "we are expecting total GAAP operating expenses of $4.9 billion and cash costs of $4.2 billion" and "we expect to end 2026 with ...

Moderna (MRNA) shares surge 8% after Q1 revenue hits $389M, tripling year-over-year and beating estimates on strong ...